SFARI | SFARI Newsletter Archive

SFARI February 2021 announcements: Summer 2020 Pilot awardees, SPARK update, Simons Searchlight research matching program and more

This issue of the SFARI newsletter includes: (1) SFARI Summer 2020 Pilot awardees, (2) SPARK update: New phenotypic data now available, (3) Simons Searchlight: Research matching program launched, (4) SFARI Gene: January 2021 data release, (5) SfN Global Connectome: Presentations by SFARI Investigators, (6) SFARI Bridge to Independence fellows discuss new research findings and career challenges at virtual retreat, (7) SFARI blog: Alice Luo Clayton, “SFARI Bridge to Independence Award program: Looking back, looking forward”, (8) Highlights of SFARI-funded research, (9) 2021 Bridge to Independence Award— Request for applications, (10) Maternal COVID-19 as a Potential Risk for Autism: Supplemental Funding for Ongoing Pregnancy cohorts – Request for applications, (11) SPARK Research Match Diversity, Equity and Inclusivity – Request for applications, (12) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (13) Upcoming lecture: Elizabeth Berry-Kravis, “Clinical trials and cyclic AMP in fragile X syndrome: A life journey.”

Neurons from stem cells, fluorescence light micrograph. Stem cells are able to differentiate into the many cell types in the human body. The type of cell they mature into depends upon the biochemical signals received. In this case, they have matured into neurons (nerve cells). They were derived from induced pluripotent stem cells (iPSC). These cells have been stained for beta III tubulin (green) and DAPI (blue). Beta-tubulin is a form of the cytoskeletal protein tubulin. DAPI is used to stain cell nuclei. This culture is from human tissue.

SFARI December 2020 announcements: New collaboration between SFARI and Nancy Lurie Marks Family Foundation, Transition in SFARI directorship update and more

This issue of the SFARI newsletter includes: (1) New collaboration between SFARI and Nancy Lurie Marks Family Foundation will generate iPS cells for autism research, (2) Transition in SFARI directorship: Update, (3) Simons Searchlight new data release, (4) SFARI Gene: October 2020 data release, (5) New Autism BrainNet website has launched, (6) ASHG 2020 Virtual Meeting: Presentations by SFARI Investigators and collaborators, (7) Workshop report: SFARI workshop discusses opportunities to study maternal infection and autism risk during COVID-19 pandemic, (8) SFARI Conversation with Kevin Eggan, (9) Highlights of SFARI-funded research, (10) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (11) 2021 Bridge to Independence Award — Request for applications, (12) Past lecture: Evan Eichler, “Rare variants and the genetics of autism.”

SFARI October 2020 announcements: 2020 Bridge to Independence fellows, new rat models to study autism spectrum disorder and more

This issue of the SFARI newsletter includes: (1) SFARI 2020 Bridge to Independence fellows announced, (2) New rat models available to study autism spectrum disorder, (3) On rat models: A SFARI Conversation with Investigators Peter Kind and Loren Frank, (4) SFARI Gene: New data release, (5) Reminder about SFARI’s acknowledgment policy, (6) SFARI Spring 2020 science meeting goes online, (7) Highlights of SFARI-funded research, (8) SFARI Supplement to Enhance Equity and Diversity (SEED) — Request for applications, (9) Past lecture: Emmanuel Mignot, “Phenotyping Sleep”.

SFARI July 2020 announcements: 2020 Research awardees, SFARI’s response to appeals for racial justice in science and society, SPARK update and more

This issue of the SFARI newsletter includes: (1) SFARI 2020 Research awardees, (2) SFARI’s response to appeals for racial justice in science and society, (3) SPARK update: New phenotypic data now available, (4) SFARI Gene: New data release, (5) Requesting SFARI data and biospecimens during COVID-19 pandemic, (6) SFARI abstracts and e-posters at INSAR 2020 Virtual, (7) SFARI Investigator and board member elected to the National Academy of Sciences, (8) SFARI Investigators and board member elected to the American Academy of Arts & Sciences, (9) Workshop report: SFARI workshop explores challenges and opportunities of gene therapies for autism spectrum disorder, (10) Highlights of SFARI-funded research, (11) Past webinar: Allyson Berent, “From parent advocate to nonprofit chief science officer, to biotherapeutic company cofounder — A personal journey through drug development for Angelman syndrome.”

SFARI April 2020 announcements: Winter 2020 Pilot awardees, Note to SFARI Investigators regarding COVID-19 and more

This issue of the SFARI newsletter includes: (1) SFARI Winter 2020 Pilot awardees, (2) Note to SFARI Investigators regarding COVID-19 epidemic, (3) SFARI 2019 Director awards, (4) Reminder: Limitations on using SFARI Simons Collection data sets and/or biospecimens, (5) SFARI meeting report: DYRK1A family meeting supports parents and scientists alike, (6) Conversation with SFARI Investigator Karen Parker, (7) 2020 SFARI Collaboration on Sex Differences in Autism — Request for applications, (8) Summer 2020 Pilot Award – Request for applications, (9) Highlights of SFARI-funded research.

SFARI February 2020 announcements: SFARI Collaboration on Sex Differences in Autism RFA, new changes implemented to SFARI Gene and more

This issue of the SFARI newsletter includes: (1) 2020 SFARI Collaboration on Sex Differences in Autism — Request for applications, (2) New changes implemented to SFARI Gene, (3) 2019 Bridge to Independence Award fellow, (4) SFARI funds to support diversity at Gordon Research Conferences, (5) SFARI meeting report: Seeing through a forest of SCN2A gene variation, (6) SFARI meeting report: Bridge to Independence fellows meeting highlights research findings and plans of the next generation of SFARI autism scientists, (7) Highlights of SFARI-funded research, (8) 2020 Bridge to Independence Award — Request for Applications, (9) Summer 2020 Pilot Award – Request for Applications, (10) Past lecture: Jason Lerch, “Autism, Autisms or Neurodevelopmental Disorders?”

SFARI January 2020 announcements: Zebrafish lines added to SFARI resources, 2019 Novel Outcome Measures in Autism Spectrum Disorder awardees and more

This issue of the SFARI newsletter includes: (1) Zebrafish lines added to SFARI resources, (2) 2019 Novel Outcome Measures in Autism Spectrum Disorder awardees, (3) Transition in SFARI directorship, (4) A joint variant call-set for all Simons Simplex Collection whole-genome sequences, (5) SFARI Investigators elected to the National Academy of Medicine, (6) SFARI blog: Paul Wang, “The need for objective outcome measures to advance intervention research in autism”, (7) SFARI blog: Wendy Chung and John Spiro, “Simons Searchlight: Rebranding and expanding the program”, (8) SFARI spring 2019 science meeting report, (9) Highlights of SFARI-funded research, (10) 2020 Bridge to Independence Award – Request for applications, (11) Upcoming lecture: Jason Lerch, “Autism, autisms or neurodevelopmental disorders?”

SFARI October 2019 announcements: Summer 2019 Pilot awardees, SPARK study identifies new candidate autism risk genes and more

This issue of the SFARI newsletter includes: (1) Summer 2019 Pilot awardees, (2) SPARK pilot study identifies novel candidate autism risk genes, (3) Simons VIP rebranded as Simons Searchlight, (4) Simons Searchlight: New data release, (5) Presentations by SFARI Investigators at ASHG 2019, (6) Presentations by SFARI Investigators at Neuroscience 2019, (7) Highlights of SFARI-funded research, (8) SFARI Social at Neuroscience 2019, (9) Simons Foundation Tech Open House, (10) Upcoming lecture: Gloria Choi, “Neuroimmune interactions shaping social behavior in mouse models for neurodevelopmental disorders”.